Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GB GROUP PLC Share Issue/Capital Change 2020

Jan 20, 2020

7662_rns_2020-01-20_62b40bd8-e236-4980-a443-688d293cdc50.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3589A

GB Group PLC

20 January 2020

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date:  20 January 2020

Name of applicant: GB GROUP PLC
Name of scheme: BLOCK SCHEME FOR

-     GB GROUP EXECUTIVE SHARE OPTIONS

-     GB GROUP SAYE SHARE OPTIONS
Period of return: From: 17 July 2019 To: 18 January 2020
Balance of unallotted securities under scheme(s) from previous return: 516,155 Ord 2.5p shares
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 5,000,000 Ord 2.5p shares
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 813,734 Ord 2.5p Shares
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 4,702,421 Ord 2.5p Shares
Number and class of securities originally admitted and the date of admission: 4,750,000 Ord 2.5p shares*
Name of contact: John Constantin (Company Secretary)
Telephone number of contact: 01244 657 327

*1,750,000 shares were admitted as part of the Executive Share Option Scheme on 15 February 2006 and 3,000,000 shares were admitted as part of the Save As You Earn Scheme on 24 July 2006. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLRFLFIELLIIFII